Detection of hemagglutinin variants of the pandemic influenza a (H1N1) 2009 virus by pyrosequencing

Journal of Clinical Microbiology

Volumn 49, Issue 4, 2011, Pages 1307-1312

  Levine, Marnie ^a,b   Sheu, Tiffany G ^a,c   Gubareva, Larisa V ^a   Mishin, Vasiliy P ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Logistics Health Incorporated (LHI)   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CYCLIC NUCLEOTIDE; GLYCINE; INFLUENZA VIRUS HEMAGGLUTININ; SERINE;

ACCURACY; AMINO ACID SUBSTITUTION; ARTICLE; CALCULATION; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; INFLUENZA VIRUS A H1N1; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS DETECTION; VIRUS HEMAGGLUTINATION; VIRUS ISOLATION;

BINDING SITES; DNA PRIMERS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIROLOGY;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 79953858651     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02424-10     Document Type: Article

References (31)

1. Anton, A., et al. 2010. D225G mutation in the hemagglutinin protein found in 3 severe cases of 2009 pandemic influenza A (H1N1) in Spain. Diagn. Microbiol. Infect. Dis. 67:207-208.
2. Bolotin, S., et al. 2009. Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates. J. Virol. Methods 158:190-194.
3. Bright, R. A., et al. 2005. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern. Lancet 366:1175-1181. (Pubitemid 41393595)
4. de la Torre, J. C., and J. J. Holland. 1990. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64:6278-6281.
5. Deyde, V. M., and L. V. Gubareva. 2009. Influenza genome analysis using pyrosequencing method: Current applications for a moving target. Expert Rev. Mol. Diagn. 9:493-509.
6. Deyde, V. M., et al. 2010. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents Chemother. 54:1102-1110.
7. Duwe, S., and B. Schweiger. 2008. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J. Virol. Methods 153:134-141.
8. Gambaryan, A. S., J. S. Robertson, and M. N. Matrosovich. 1999. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 258:232-239. (Pubitemid 29390232)
9. Gubareva, L. V., L. Kaiser, M. N. Matrosovich, Y. Soo Hoo, and F. G. Hayden. 2001. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J. Infect. Dis. 183:523-531. (Pubitemid 32147507)
10. Kalvatchev, Z., R. Walder, D. Garzaro, and M. Barrios. 2000. Detection of genetic diversity among bovine immunodeficiency virus population by singlestrand conformation polymorphism analysis. Viral Immunol. 13:373-381.
11. Kilander, A., R. Rykkvin, S. G. Dudman, and O. Hungnes. 2010. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 15(9):pii=19546.
12. Lackenby, A., J. Democratis, M. M. Siqueira, and M. C. Zambon. 2008. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir. Ther. 13:809-820.
13. Langaee, T., and M. Ronaghi. 2005. Genetic variation analyses by pyrosequencing. Mutat. Res. 573:96-102.
14. Lin, J. H., et al. 2008. Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis. J. Clin. Microbiol. 46:1090-1097.
15. Lindstrom, A., J. Odeberg, and J. Albert. 2004. Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J. Clin. Microbiol. 42:4788-4795. (Pubitemid 39362404)
16. Mas, A., C. Lopez-Galindez, I. Cacho, J. Gomez, and M. A. Martinez. 2010. Unfinished stories on viral quasispecies and Darwinian views of evolution. J. Mol. Biol. 397:865-877.
17. Miller, R. R., A. R. MacLean, R. N. Gunson, and W. F. Carman. 2010. Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill. 15(16):19498=pii.
18. O'Meara, D., et al. 2001. Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing. J. Clin. Microbiol. 39: 464-473. (Pubitemid 32150803)
19. Parvin, J. D., A. Moscona, W. T. Pan, J. M. Leider, and P. Palese. 1986. Measurement of the mutation rates of animal viruses: Influenza A virus and poliovirus type 1. J. Virol. 59:377-383. (Pubitemid 16013985)
20. Pourmand, N., et al. 2006. Rapid and highly informative diagnostic assay for H5N1 influenza viruses. PLoS One 1:e95.
21. Ronaghi, M., S. Karamohamed, B. Pettersson, M. Uhlen, and P. Nyren. 1996. Real-time DNA sequencing using detection of pyrophosphate release. Anal. Biochem. 242:84-89. (Pubitemid 26378519)
22. Reference deleted.
23. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
24. Smee, D. F., et al. 2007. Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor. Antivir. Chem. Chemother. 18:317-327. (Pubitemid 351448499)
25. Stewart, P. L., and G. R. Nemerow. 1997. Recent structural solutions for antibody neutralization of viruses. Trends Microbiol. 5:229-233. (Pubitemid 27348680)
26. Tsiatis, A. C., et al. 2010. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: Diagnostic and clinical implications. J. Mol. Diagn. 12:425-432.
27. Viboud, C., et al. 2006. Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 24:6701-6707. (Pubitemid 46107171)
28. Wang, B., et al. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res. 87:16-s21.
29. Wong, C. W., et al. 2004. Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. Genome Res. 14: 398-405. (Pubitemid 38386606)
30. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic. 2010. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 362:1708-1719.
31. Yang, Z. J., M. Z. Tu, J. Liu, X. L. Wang, and H. Z. Jin. 2006. Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B. World J. Gastroenterol. 12:7192-7196. (Pubitemid 44890653)